The market is driven by the consumer awareness of health care resulting in access for treatment along with increase in the global ageing populace which faces these kind of health problems at that age.
Global Blood Plasma Market is a growing market with key players holding dominant positions and is classified on the basis of drugs market. Global Blood Plasma Market has been growing at an average pace over the last five years on account of growing number of old people and the demand in the different regions .
During 2015-20, Global Blood Plasma Market is anticipated to grow at an increased rate on account of the rapid increase of the healthcare expenditure on the diseases related to the blood plasma i.e. immunodeficiency, clotting disabilities etc..
The plasma market is still on the growing end at a CAGR of 10.54% where major players are having strong presence in market, considering more number of patients being treated for these diseases. The growth in ageing population, rise in healthcare expenditure and R&D of the new products also create a demand for the products making the market to grow at a steady pace.
According to Azoth Analytics research report, Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players), global blood plasma market is projected to exhibit a CAGR of 10.54% during 2015 - 2020. Few of the leading companies operating in blood plasma market in world include CSL Behring, Baxter, Grifols SA and Octapharma, etc.
Scope of the Report
“Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players)” analyses the following aspects of Global Blood Plasma Market:
• Analysis of Key Market Segments - IVIG, Albumin, Factor VIII
• Analysis of Key Market Segments - IVIG, Albumin, Factor VIII BY Geography – North America, Europe, APAC
• Executive Summary – Market, Drivers & Challenges and Trends.
• Global Blood Plasma Market, Size & Forecast.
Why You Should Buy This Report?
• To gain an in-depth understanding of Global Blood Plasma Market
• To identify the on-going trends and anticipated growth in the next five years
• To help industry consultants, blood plasma manufacturers, suppliers and distributors align their market-centric strategies
• To gain insights on the prevalent market entry strategies in blood plasma market for domestic as well as foreign companies
• To obtain research based business decision and add weight to presentations and marketing material
• To gain competitive knowledge of leading players
• To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer’s specific needs
2. Product Overview
3. Executive Summary
4. Global Blood Plasma Market: An Analysis
4.1. Global Blood Plasma Market: Size, Growth and Forecast
4.1.1. By Value & Forecast
4.2. Global Blood Plasma Market: Segment Shares & Analysis
4.2.1. By Product Type
4.2.2. By Company
4.3. Global Albumin Type Blood Plasma Market: Size, Growth and Forecast
4.3.1. By Volume
4.3.2. By Value
4.3.3 By Company
4.4. Global IVIG Type Blood Plasma Market: Size, Growth and Forecast
4.4.1. By Value
4.4.2 By Volume
4.5. Global Factor VIII Type Blood Plasma Market: Size, Growth and Forecast
4.5.2 By Value
4.5.3 By Volume
4.6. Other Blood Products Market: Size, Growth and Forecast
4.6.1. By Value (Forecast 2020F)
5. North America Blood Plasma Market: Size, Growth and Forecast
5.2. By Value (Forecast 2015E-2020F)
5.3. Factors Affecting Market
6. APAC Blood Plasma Market: Size, Growth and Forecast
6.2. By Value (Forecast 2015E-2020F)
6.3. Factors Affecting Market
7. Europe Blood Plasma Market: Size, Growth and Forecast
7.1. By Value (Forecast 2015E-2020F)
8. RoW Blood Plasma Market: Size, Growth and Forecast
8.2. By Value (Forecast 2015E-2020F)
8.3. Factors Affecting Market
9. Blood Plasma Market Trends
9.1.1. Solid and Stable Pricing Power in IG Market
9.1.2. Fast Growth of SCIG Market
9.1.3. Industrial Fractionators Planning Capacity Expansion
9.1.4. Increase in Albumin Market in China
9.1.5. Immunoglobulin Segment- High Profitability and Strength
10. Global Blood Plasma Market Dynamics
10.1. Growth Drivers
10.1.1. Augmentation in Plasma accumulations in the US
10.1.2. Rise in Global Healthcare Expenditure
10.1.3. Growth in Ageing Population
10.1.4. Growth in Male Population
10.1.5. Development Potential from New Indications
10.2.1. Rivalry from Recombinant Factor VIII
10.2.2. Prospective Threat to Immunoglobulin Market
10.2.3. Costing Pressure in Tenders in Plasma-Derived FVIII Market
10.2.4. High Manufacturing and Safety Cost
11. Blood Plasma Market: Policy and Regulatory Landscape
11.1. WHO Blood Safety Regulations
11.2. FDA Blood Safety Regulations
11.3. CANADA CAN/CSA-Z902-10 (R2015) - Blood and blood components
11.4. PHARMACEUTICAL AND FOOD SAFETY BUREAU (PFSB) JAPAN
11.5. UK Blood Safety Regulations
11.6. Australia Blood Safety Regulations
11.7. India Plasma Product Safety Regulations
12. Blood Plasma Market: Value Chain Analysis
12.1. Supply Chain Diagram
12.2. BLOOD PLASMA SUPPLY CHAIN
13. Blood Plasma Trade Data Analysis
13.1. Top 5 Nations with Import By Volume (Million KGS)
13.2. Top 5 Nations with Export By Volume (Million KGS)
13.3. Top 5 Nations with Import by Value (Billion $)
13.4. Top 5 Nations with Export by Value (Billion $)
14. Blood Plasma Market: Porter’s Five Force Analysis
14.1. Porter Five Force Model Blood Plasma
15. Blood Plasma Market: Competitive landscape
15.1. Blood Plasma Market: Company Financials
15.1.1. Top 5 Companies Sales
15.1.2. Bottom 5 Companies Sales
15.1.3. Top 5 Companies EBITDA
15.1.4. Bottom 5 Companies EBITDA
15.1.5. Top 5 Companies EBIT
15.1.6. Bottom 5 Companies EBIT
15.1.7. Top 5 Companies PBT
15.1.8. Bottom 5 Companies PBT
15.1.9. Top 5 Companies PAT
15.1.10. Bottom 5 Companies PAT
15.2 Company Ratios
15.2.1. Top 5 Companies Current Ratio
15.2.2. Bottom 5 Companies Current Ratio
15.2.3. Top 5 Companies Profit Margin
15.2.4. Bottom 5 Companies Profit Margin
15.2.5. Top 5 Companies Debt Equity Ratio
16. Global Blood Plasma Market: Company Profiles
16.1. CSL Ltd.
16.2 Baxter International Inc
16.3 Grifols S.A
16.4 Antares Pharma Inc
16.5 Emergent BioSolutions, Inc.
16.6 AMAG Pharmaceuticals, Inc.
16.9 Biota Pharmaceuticals, Inc.
16.10 BioDelivery Sciences International, Inc.
17. Strategic Recommendations
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.